Hi, what are you looking for?
A new approach replaces rilpivirine with lenacapavir, a long-acting drug that attacks HIV in a different way.
Injections were found to be more effective at keeping the virus suppressed than the tablets, so efforts should be made to make this treatment...
Long-acting HIV therapies are becoming an increasingly competitive treatment category. While efficacy remains essential, differentiation is now shifting towards factors such as dosing convenience,...
A one-time regimen of therapies given to newborns within three days of birth may permanently clear the virus.
Although modern medicines have transformed HIV into a manageable long-term condition, taking medication every day can still contribute to stigma and treatment fatigue for...
Although new HIV infections and AIDS-related deaths are at their lowest levels in more than 30 years, the current HIV response is extremely fragile.